AMRN Amarin Corp Plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMRN

Price (delayed)

$0.7963

Market cap

$327.17M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.13

Enterprise value

$121.09M

Amarin is a rapidly growing, innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From its scientific research foundation to its focus on clinical trials, and now its ...

Highlights
AMRN's net income is up by 42% YoY and by 11% from the previous quarter
The company's EPS rose by 41% YoY and by 13% QoQ
Amarin's gross profit has decreased by 31% YoY and by 10% QoQ
The revenue is down by 23% year-on-year and by 10% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.amarincorp.com
Peers: ABBV ALKS TEVA AZN

Key stats

What are the main financial stats of AMRN
Market
Shares outstanding
410.87M
Market cap
$327.17M
Enterprise value
$121.09M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.6
Price to sales (P/S)
1.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.44
Earnings
Revenue
$277.46M
EBIT
-$48.98M
EBITDA
-$46.02M
Free cash flow
$754,000
Per share
EPS
-$0.13
Free cash flow per share
$0
Book value per share
$1.33
Revenue per share
$0.68
TBVPS
$1.88
Balance sheet
Total assets
$790.01M
Total liabilities
$244.08M
Debt
$8.39M
Equity
$545.94M
Working capital
$463.55M
Liquidity
Debt to equity
0.02
Current ratio
3.07
Quick ratio
1.89
Net debt/EBITDA
4.48
Margins
EBITDA margin
-16.6%
Gross margin
53.9%
Net margin
-19%
Operating margin
-23%
Efficiency
Return on assets
-6.3%
Return on equity
-9.5%
Return on invested capital
-14.6%
Return on capital employed
-8.7%
Return on sales
-17.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMRN stock price

How has the Amarin stock price performed over time
Intraday
0.8%
1 week
2.09%
1 month
13.76%
1 year
-30.15%
YTD
-8.47%
QTD
15.41%

Financial performance

How have Amarin's revenue and profit performed over time
Revenue
$277.46M
Gross profit
$149.52M
Operating income
-$63.83M
Net income
-$52.61M
Gross margin
53.9%
Net margin
-19%
AMRN's net income is up by 42% YoY and by 11% from the previous quarter
AMRN's operating income is up by 33% year-on-year and by 6% since the previous quarter
Amarin's gross profit has decreased by 31% YoY and by 10% QoQ
AMRN's net margin is up by 25% year-on-year

Growth

What is Amarin's growth rate over time

Valuation

What is Amarin stock price valuation
P/E
N/A
P/B
0.6
P/S
1.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.44
The company's EPS rose by 41% YoY and by 13% QoQ
AMRN's P/B is 79% below its 5-year quarterly average of 2.9 and 14% below its last 4 quarters average of 0.7
The equity has declined by 7% year-on-year
The P/S is 68% less than the 5-year quarterly average of 3.7 and 9% less than the last 4 quarters average of 1.3
The revenue is down by 23% year-on-year and by 10% since the previous quarter

Efficiency

How efficient is Amarin business performance
AMRN's ROE is up by 39% YoY and by 10% from the previous quarter
The ROIC has increased by 39% YoY and by 3.9% QoQ
Amarin's ROA has increased by 37% YoY and by 10% from the previous quarter
The company's return on sales rose by 31% YoY

Dividends

What is AMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMRN.

Financial health

How did Amarin financials performed over time
AMRN's total liabilities is down by 13% since the previous quarter and by 11% year-on-year
The current ratio has grown by 10% from the previous quarter and by 10% YoY
AMRN's debt is 98% smaller than its equity
AMRN's debt is down by 15% year-on-year and by 4% since the previous quarter
The equity has declined by 7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.